Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Diabetic hyperglycaemia causes a variety of pathological changes in small vessels, arteries and peripheral nerves. Vascular endothelial cells are an important target of hyperglycaemic damage, but the mechanisms underlying this damage are not fully understood. Three seemingly independent biochemical pathways are involved in the pathogenesis: glucose-induced activation of protein kinase C isoforms; increased formation of glucose-derived advanced glycation end-products; and increased glucose flux through the aldose reductase pathway. The relevance of each of these pathways is supported by animal studies in which pathway-specific inhibitors prevent various hyperglycaemia-induced abnormalities. Hyperglycaemia increases the production of reactive oxygen species inside cultured bovine aortic endothelial cells. Here we show that this increase in reactive oxygen species is prevented by an inhibitor of electron transport chain complex II, by an uncoupler of oxidative phosphorylation, by uncoupling protein-1 and by manganese superoxide dismutase. Normalizing levels of mitochondrial reactive oxygen species with each of these agents prevents glucose-induced activation of protein kinase C, formation of advanced glycation end-products, sorbitol accumulation and NFkappaB activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prolonged elevated glucose could also signal as a cell stressor through multiple pathways, including hyperosmolarity (McGinn et al., 2003), protein kinase C (PKC) activation (Mandarino, 1992), and oxidative damage (Nishikawa et al., 2000), likely involving pS-STAT3, as well as pY-STAT3.”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Nishikawa et al., 2000
In the citing paper
“Certainly ROSs are known to play a substantive role in both insulin resistance [549-556] and in a variety of diabetic sequelae [95,557-559], and mitochondrial dysfunction may be an early step in this [560].”
In the citing paper
“A variety of studies have shown that iron is involved in these signalling processes [1839,1996,2015,2081-2085], probably again acting upstream of the IKK [557,2083,2086,2087].”
In the citing paper
“The preferential use of the liver to dispose a significant amount of the ingested glucose during first pass, along with a 60–70% hepatic clearance of insulin, protect the peripheral circulation from excessive hyperglycemia/hyperinsulinemia in the postprandial period [35,36,37,38,39,40,41,42,43].”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [36]
In the citing paper
“In this way, it was showed that a diet saturated in fats and carbohydrates can cause several mood-related brain mechanisms damage [305].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [305]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Korshunov, S. S., Skulachev, V. P., & Starkov, A. A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01159-9 · Cited by 1,727 · cited 1×
“There appears to be a threshold value above which superoxide production is markedly increase”
BackgroundProtein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330 · cited 1×
“Three seemingly independent biochemical pathways are involved in the pathogenesis: glucose-induced activation of protein kinase C isoform”
BackgroundDiseases of the mitochondrial DNA
Wallace, D. C. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.005523 · Cited by 1,319 · cited 1×
“Electron flow through the mitochondrial electron transport chain is carried out by four inner-membrane-associated enzyme complexes, with cytochrome c and the mobile carrier ubiquinon”
BackgroundAdvanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Self-citationPark, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,104 · cited 1×
“The relevance of each of these pathways is supported by animal studies in which pathway-specific inhibitors prevent various hyperglycaemia-induced abnormalitie”
BackgroundAmelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103 · cited 1×
“The relevance of each of these pathways is supported by animal studies in which pathway-specific inhibitors prevent various hyperglycaemia-induced abnormalitie”
BackgroundTrumpower, B. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38410-8 · Cited by 595
Manna, S. K., Zhang, H. J., Yan, T., Oberley, L. W., & Aggarwal, B. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13245 · Cited by 564 · cited 1×
“Overexpression of manganese superoxide dismutase (Mn-SOD), the mitochondrial form of this antioxidant enzym”
BackgroundShinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P., Thorpe, S. R., Onorato, J., & Brownlee, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119885 · Cited by 513
Self-citationLee, A. Y., Chung, S. K., & Chung, S. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2780 · Cited by 310 · cited 1×
“; and increased glucose flux through the aldose reductase pathwa”
Background
Research works printed but not linked: 1
- National Diabetes Data Group Diabetes in America 2nd edn (National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, USA, 1994).
Cited by
Items 301–400 of 1,040
Biological Properties of Vitamins of the B-Complex, Part 1: Vitamins B1, B2, B3, and B5
Hrubša, M., Siatka, T., Nejmanová, I., Vopršalová, M., Kujovská Krčmová, L., Matoušová, K., Javorská, L., Macáková, K., Mercolini, L., Remião, F., et al. (2022) · Nutrients · doi:10.3390/nu14030484 · Cited by 263
Stern, D., Du Yan, S., Fang Yan, S., & Marie Schmidt, A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00160-6 · Cited by 281
Zheng, Z., Chen, H., Li, J., Li, T., Zheng, B., Zheng, Y., Jin, H., He, Y., Gu, Q., & Xu, X. (2012) · Diabetes · doi:10.2337/db11-0416 · Cited by 282
Zhang, D., Jin, W., Wu, R., Li, J., Park, S.-A., Tu, E., Zanvit, P., Xu, J., Liu, O., Cain, A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.001 · Cited by 272
Batandier, C., Guigas, B., Detaille, D., El-Mir, M., Fontaine, E., Rigoulet, M., & Leverve, X. M. (2006) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-006-9003-8 · Cited by 279
Slyepchenko, A., Maes, M., Jacka, F. N., Köhler, C. A., Barichello, T., McIntyre, R. S., Berk, M., Grande, I., Foster, J. A., Vieta, E., et al. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448957 · Cited by 278
Beckman, J. A., Goldfine, A. B., Gordon, M. B., Garrett, L. A., & Creager, M. A. (2002) · Circulation Research · doi:10.1161/hh0102.102359 · Cited by 277
Bajaj, S., & Khan, A. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.104057 · Cited by 259
“These findings support the feasibility of targeting the triggering role of mitochondrial superoxide production in hyperglycemia-induced tissue damage.[11]”
Acute Hyperglycemia Induces Nitrotyrosine Formation and Apoptosis in Perfused Heart From Rat
Ceriello, A., Quagliaro, L., D’Amico, M., Di Filippo, C., Marfella, R., Nappo, F., Berrino, L., Rossi, F., & Giugliano, D. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1076 · Cited by 279
“centration, will produce, at the mitochondrial level, not only energy but also a large quantity of O2 (38).”
InfluentialCatalase Protects Cardiomyocyte Function in Models of Type 1 and Type 2 Diabetes
Ye, G., Metreveli, N. S., Donthi, R. V., Xia, S., Xu, M., Carlson, E. C., & Epstein, P. N. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1336 · Cited by 279
“Recent proposals (9) suggest that overproduction of reactive oxygen species (ROS) may be the initiating event leading to long-term development of diabetic complications.”
BackgroundOxidants in Chronic Kidney Disease
Shah, S. V., Baliga, R., Rajapurkar, M., & Fonseca, V. A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050500 · Cited by 276
“Mitochondrial metabolism also has been suggested as an important source for the generation of oxidants in response to high glucose (48), similar to that proposed in the vascular bed (46,47).”
BackgroundZhou, S., Chen, H.-Z., Wan, Y.-Z., Zhang, Q.-J., Wei, Y.-S., Huang, S., Liu, J.-J., Lu, Y.-B., Zhang, Z.-Q., Yang, R.-F., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.243592 · Cited by 273
Forbes, J. M., Cooper, M. E., Thallas, V., Burns, W. C., Thomas, M. C., Brammar, G. C., Lee, F., Grant, S. L., Burrell, L. M., Jerums, G., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3274 · Cited by 277
“(5), who emphasized the pivotal role of mitochondrial oxidation in diabetes complications.”
InfluentialDiabetes and Alpha Lipoic Acid
Golbidi, S., Badran, M., & Laher, I. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00069 · Cited by 270
“DHLA also reduces the oxidized form of CoQ10, which can additionally reduce the alpha-tocopheroxyl radical (Smith et al., 2004).”
BackgroundBai, Y., Cui, W., Xin, Y., Miao, X., Barati, M. T., Zhang, C., Chen, Q., Tan, Y., Cui, T., Zheng, Y., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.01.008 · Cited by 274
Mechanisms of Endothelial Dysfunction, Injury, and Death
Pober, J. S., Min, W., & Bradley, J. R. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092155 · Cited by 272
Traumatic brain injury: pathophysiology for neurocritical care
Kinoshita, K. (2016) · Journal of Intensive Care · doi:10.1186/s40560-016-0138-3 · Cited by 257
“Vascular endothelial cells are a significant target of hyperglycemic damage [71], but the mechanisms underlying such damage to the cerebral microvasculature are not fully understood.”
BackgroundHa, H., Yu, M. R., Choi, Y. J., Kitamura, M., & Lee, H. B. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134894 · Cited by 273
Peroxynitrite and Vascular Endothelial Dysfunction in Diabetes Mellitus
Zou, M.-H., Cohen, R. A., & Ullrich, V. (2004) · Endothelium · doi:10.1080/10623320490482619 · Cited by 270
F 2 -Isoprostanes in Human Health and Diseases: From Molecular Mechanisms to Clinical Implications
Basu, S. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1956 · Cited by 268
“Abundant evidence supports that reactive free-radical species are physiologically very important to exert a variety of vital biochemical reactions, including lipid oxidation that systematizes many significant physiologic functions, including cell signaling, vascular tone, cell generation and degeneration, control of c…”
Rowan, S., Jiang, S., Korem, T., Szymanski, J., Chang, M.-L., Szelog, J., Cassalman, C., Dasuri, K., McGuire, C., Nagai, R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702302114 · Cited by 272
Self-citationRole of endothelial dysfunction in insulin resistance
Hsueh, W. A., & Quiñones, M. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00611-8 · Cited by 276
Hansell, P., Welch, W. J., Blantz, R. C., & Palm, F. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12034 · Cited by 269
“Inhibition of mitochondrial O 2 formation totally inhibits all the classical pathways known to result in diabetes-related diseases.(89)”
BackgroundMatsuda, H., Wang, T., Managi, H., & Yoshikawa, M. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.09.045 · Cited by 259
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes
STERN, D., YAN, S., YAN, S., & SCHMIDT, A. (2002) · Ageing Research Reviews · doi:10.1016/s0047-6374(01)00366-9 · Cited by 266
Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications
Sas, K. M., Kayampilly, P., Byun, J., Nair, V., Hinder, L. M., Hur, J., Zhang, H., Lin, C., Qi, N. R., Michailidis, G., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86976 · Cited by 268
“Discussion The prevailing theory of how hyperglycemia results in complications is through the glucose-derived increase in mitochondrial superoxide production (31, 32).”
BackgroundQUAGLIARO, L., PICONI, L., ASSALONI, R., DAROS, R., MAIER, A., ZUODAR, G., & CERIELLO, A. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.015 · Cited by 268
Mechanisms of diabetic vasculopathy: an overview
Cooper, M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01323-6 · Cited by 267
Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy
Kaludercic, N., & Di Lisa, F. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00012 · Cited by 263
“Reduction in mitochondrial ROS formation obtained either through cardiacspecific Mn-SOD overexpression or following stimulation of AMPK activity, prevented mitochondrial damage and many fatty acid- or hyperglycemia-induced events, both in vitro and in vivo (113–116).”
BackgroundInfluentialMitochondria in the diabetic heart
Bugger, H., & Abel, E. D. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq239 · Cited by 260
Oxidative and nitrosative stress in brain mitochondria of diabetic rats
Mastrocola, R., Restivo, F., Vercellinatto, I., Danni, O., Brignardello, E., Aragno, M., & Boccuzzi, G. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06269 · Cited by 268
“The direct glucose toxicity in the neurons is especially due to increased intracellular glucose oxidation (Nishikawa et al. 2000), which leads to an increase in reactive species production (Bonnefont-Rousselot 2002, Evans et al.”
BackgroundInfluentialDetaille, D., Guigas, B., Chauvin, C., Batandier, C., Fontaine, E., Wiernsperger, N., & Leverve, X. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2179 · Cited by 263
“Recently, compelling evidence has been provided that 1) onset and progression of diabetes and its complications are closely associated with oxidative stress (2,3) and 2) generation of reactive oxygen species (ROS) by the mitochondrial respiratory chain promotes seemingly independent biochemical pathways involved in th…”
BackgroundOxidative Stress, Lens Gap Junctions, and Cataracts
Berthoud, V. M., & Beyer, E. C. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2119 · Cited by 258
“In diabetic cataracts, hyperglycemia leads to an increase in superoxide in mitochondria (108, 134), and increased superoxide dismutase (SOD) activity has been observed by some investigators (140), but not others (110).”
Mitochondrial involvement and oxidative stress in temporal lobe epilepsy
Rowley, S., & Patel, M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.002 · Cited by 258
“where increased glycolytic rates increase ROS production due to large flux of electron donors from the TCA cycle, generating a high mitochondrial membrane potential that can inhibit electron transport and therefore increase the production of O2 [78].”
BackgroundOxidative stress as a therapeutic target in diabetes: revisiting the controversy
Wiernsperger, N. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70072-1 · Cited by 257
“When the latter fails OST develops and it was recently proposed that this mechanism is responsible for the activation of all major pathways underlying the different components of vascular diabetic complications (glycation, PKC activation, sorbitol pathway) [8].”
BackgroundHodgson, J., Watts, G., Playford, D., Burke, V, & Croft, K. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601464 · Cited by 252
“This is an effect that may be particularly important in diabetic subjects (Nishikawa et al, 2000).”
BackgroundZou, M.-H., Shi, C., & Cohen, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.1.198 · Cited by 261
“Potential sources of this O2 could be NAD(P)H oxidases (29), xanthine oxidase (2), mitochondria (4), or NO synthase (30).”
BackgroundPaneni, F., Mocharla, P., Akhmedov, A., Costantino, S., Osto, E., Volpe, M., Lüscher, T. F., & Cosentino, F. (2012) · Circulation Research · doi:10.1161/circresaha.112.266593 · Cited by 256
Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes
Shen, X., Zheng, S., Thongboonkerd, V., Xu, M., Pierce, W. M., Klein, J. B., & Epstein, P. N. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00047.2004 · Cited by 258
“Mitochondria are a major source of ROS in diabetes (7, 37).”
BackgroundInfluentialNoh, H., Oh, E. Y., Seo, J. Y., Yu, M. R., Kim, Y. O., Ha, H., & Lee, H. B. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00086.2009 · Cited by 254
Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin
Okamoto, T., Yamagishi, S., Inagaki, Y., Amano, S., Koga, K., Abe, R., Takeuchi, M., Ohno, S., Yoshimura, A., & Makita, Z. (2002) · The FASEB Journal · doi:10.1096/fj.02-0030fje · Cited by 258
Self-citationPiconi, L., Quagliaro, L., & Ceriello, A. (2003) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2003.177 · Cited by 255
“, PKC activation, AGE formation and sorbitol accumulation) (39).”
BackgroundYaribeygi, H., Atkin, S. L., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27164 · Cited by 243
“MRC is composed of a four protein complex, I–IV, and is considered as a major potential source of free radical generation during chronic hyperglycemia (Nishikawa et al., 2000; Sakai et al., 2003).”
BackgroundInfluentialUrinary biomarkers of oxidative status
Il'yasova, D., Scarbrough, P., & Spasojevic, I. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.06.012 · Cited by 235
Kawamori, D., Kaneto, H., Nakatani, Y., Matsuoka, T.-A., Matsuhisa, M., Hori, M., & Yamasaki, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508510200 · Cited by 254
Etoh, T., Inoguchi, T., Kakimoto, M., Sonoda, N., Kobayashi, K., Kuroda, J., Sumimoto, H., & Nawata, H. (2003) · Diabetologia · doi:10.1007/s00125-003-1205-6 · Cited by 253
“It has been postulated that hyperglycaemia could produce ROS through various mechanisms such as enhanced formation of advanced glycation endproducts (AGEs) [3], altered polyol pathway activity [2, 7] and increased superoxide release from mitochondria [8].”
BackgroundIdentification of a Ryanodine Receptor in Rat Heart Mitochondria
Beutner, G., Sharma, V. K., Giovannucci, D. R., Yule, D. I., & Sheu, S.-S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101486200 · Cited by 246
Carlo, M. D., & Loeser, R. F. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11338 · Cited by 253
Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential
Yang, D., Livingston, M. J., Liu, Z., Dong, G., Zhang, M., Chen, J.-K., & Dong, Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2639-1 · Cited by 252
“Normalizing mitochondrial superoxide production has been shown to block high glucose-induced metabolic changes [133].”
BackgroundTranscriptional responses to oxidative stress: Pathological and toxicological implications
Ma, Q. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.004 · Cited by 251
Role of reactive oxygen species in the pathogenesis of diabetic nephropathy
Ha, H., Hwang, I.-A., Park, J. H., & Lee, H. B. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.017 · Cited by 249
Diabetes‐associated macrovasculopathy: pathophysiology and pathogenesis
Rahman, S., Rahman, T., Ismail, A. A., & Rashid, A. R. A. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00655.x · Cited by 248
Role of Oxidative Stress in Pancreatic β-Cell Dysfunction
Kajimoto, Y., & Kaneto, H. (2004) · Mitochondrial Pathogenesis · doi:10.1007/978-3-662-41088-2_17 · Cited by 248
Qi, H., Casalena, G., Shi, S., Yu, L., Ebefors, K., Sun, Y., Zhang, W., D’Agati, V., Schlondorff, D., Haraldsson, B., et al. (2017) · Diabetes · doi:10.2337/db16-0695 · Cited by 245
“Altogether, our findings are consistent with the longstanding model that overproduction of superoxide by the mitochondrial electron transport chain is a unifying central mechanism underlying diabetic complications (52).”
Resultl-Citrulline Supplementation: Impact on Cardiometabolic Health
Allerton, T., Proctor, D., Stephens, J., Dugas, T., Spielmann, G., & Irving, B. (2018) · Nutrients · doi:10.3390/nu10070921 · Cited by 231
Mitochondria in Vascular Health and Disease
Dromparis, P., & Michelakis, E. D. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183804 · Cited by 236
Camici, G. G., Schiavoni, M., Francia, P., Bachschmid, M., Martin-Padura, I., Hersberger, M., Tanner, F. C., Pelicci, P., Volpe, M., Anversa, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609656104 · Cited by 249
Postprandial recruitment of neutrophils may contribute to endothelial dysfunction
van Oostrom, A. J. H. H. M., Sijmonsma, T. P., Verseyden, C., Jansen, E. H. J. M., de Koning, E. J. P., Rabelink, T. J., & Castro Cabezas, M. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200419-jlr200 · Cited by 249
“Glucose induces the production of mitochondrial reactive oxygen species (ROS) in endothelial cells, thereby initiating a pro-inflammatory cascade and reducing NO (38;39).”
BackgroundRedox Signaling, Vascular Function, and Hypertension
Lee, M. Y., & Griendling, K. K. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1986 · Cited by 242
Weekers, F., Giulietti, A.-P., Michalaki, M., Coopmans, W., Van Herck, E., Mathieu, C., & Van den Berghe, G. (2003) · Endocrinology · doi:10.1210/en.2003-0697 · Cited by 245
Mariappan, N., Elks, C. M., Sriramula, S., Guggilam, A., Liu, Z., Borkhsenious, O., & Francis, J. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp305 · Cited by 240
Lewis, P., Stefanovic, N., Pete, J., Calkin, A. C., Giunti, S., Thallas-Bonke, V., Jandeleit-Dahm, K. A., Allen, T. J., Kola, I., Cooper, M. E., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.664250 · Cited by 246
“purchased from Applied Biosystems (ABI, Foster City, CA, USA), have been described by us previously.(2,6) Probes and primers for VEGF, Sod1, Sod2, gp91phox, NF-ĸB and RAGE are”
MethodInfluentialPatel, T. P., Rawal, K., Bagchi, A. K., Akolkar, G., Bernardes, N., Dias, D. D. S., Gupta, S., & Singal, P. K. (2016) · Heart Failure Reviews · doi:10.1007/s10741-015-9515-6 · Cited by 240
“Thus, HO-1 is one of the major defense against oxidative stress which becomes vulnerable and contributes to mitochondrial oxidative stress in diabetes mellitus [51].”
BackgroundMitochondrial dysfunction in pancreatic β cells
Supale, S., Li, N., Brun, T., & Maechler, P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.06.002 · Cited by 231
Redox Signaling in Diabetic Wound Healing Regulates Extracellular Matrix Deposition
Kunkemoeller, B., & Kyriakides, T. R. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7263 · Cited by 234
“6) (68, 122).”
InfluentialMolecular mechanisms beyond glucose transport in diabetes-related male infertility
Alves, M. G., Martins, A. D., Rato, L., Moreira, P. I., Socorro, S., & Oliveira, P. F. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.011 · Cited by 241
“Hyperglycemia-induced superoxide overproduction inhibits glucose-6phosphate dehydrogenase [137] thus decreasing the antioxidant defenses and ROS overproduction and is also intimately related with mitochondrial dysfunction.”
BackgroundDiabetes increases mortality after myocardial infarction by oxidizing CaMKII
Luo, M., Guan, X., Luczak, E. D., Lang, D., Kutschke, W., Gao, Z., Yang, J., Glynn, P., Sossalla, S., Swaminathan, P. D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65268 · Cited by 240
“Mitochondria constitutively generate superoxide radicals as a by-product of electron transport and are also important sources for intracellular ROS production triggered by hyperglycemia (58, 59).”
Suleiman, M., Hammerman, H., Boulos, M., Kapeliovich, M. R., Suleiman, A., Agmon, Y., Markiewicz, W., & Aronson, D. (2005) · Circulation · doi:10.1161/01.cir.0000155235.48601.2a · Cited by 245
Del Carlo, M., & Loeser, R. F. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10056 · Cited by 244
Bagul, P. K., Deepthi, N., Sultana, R., & Banerjee, S. K. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.06.006 · Cited by 241
“Several mechanisms like overproduction of mitochondrial reactive oxygen species (ROS) [5], increased glucose auto-oxidation, altered myocardial energy metabolism [6] and increased synthesis of advanced glycation end-products (AGEs) [7] have been proposed for hyperglycemia-induced oxidative damage in the diabetic heart.”
BackgroundDiNicolantonio, J. J., Bhutani, J., & O'Keefe, J. H. (2015) · Open Heart · doi:10.1136/openhrt-2015-000327 · Cited by 228
“29 30 Hyperglycaemia increases the electron fl ow in the Kreb ’ s cycle, thus accumulation of nicotinamide adenine dinucleotide (NADH) and fl avin adenine dinucleotide (FADH2), and an increased proton transport via the inner mitochondrial membrane.”
BackgroundDiabetic nephropathy: an insight into molecular mechanisms and emerging therapies
Warren, A. M., Knudsen, S. T., & Cooper, M. E. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1624721 · Cited by 245
“Metabolic processes such as oxidative stress, the formation of advanced glycation endproducts (AGE), cellular signaling and renewal processes, fibrosis and epigenetics are key aspects of the pathophysiology of DKD and potential targets for future drug therapy.”
BackgroundInfluentialNaturally occurring inhibitors against the formation of advanced glycation end-products
Peng, X., Ma, J., Chen, F., & Wang, M. (2011) · Food & Function · doi:10.1039/c1fo10034c · Cited by 244
Jain, S. K., & Lim, G. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00462-7 · Cited by 242
Testa, R., Bonfigli, A. R., Prattichizzo, F., La Sala, L., De Nigris, V., & Ceriello, A. (2017) · Nutrients · doi:10.3390/nu9050437 · Cited by 225
“Brownlee has postulated that there is an excess of superoxide anion in the mitochondria of endothelial cells in response to hyperglycemia, which gives rise to diabetes complications [17].”
BackgroundPerivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword
Qi, X.-Y., Qu, S.-L., Xiong, W.-H., Rom, O., Chang, L., & Jiang, Z.-S. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0777-x · Cited by 226
Acute hyperglycemia induces an oxidative stress in healthy subjects
Marfella, R., Quagliaro, L., Nappo, F., Ceriello, A., & Giugliano, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13727 · Cited by 242
Glycation in diabetic neuropathy: Characteristics, consequences, causes, and therapeutic options
Thornalley, P. J. (2002) · International Review of Neurobiology · doi:10.1016/s0074-7742(02)50072-6 · Cited by 243
Visualizing Superoxide Production in Normal and Diabetic Rat Islets of Langerhans
Bindokas, V. P., Kuznetsov, A., Sreenan, S., Polonsky, K. S., Roe, M. W., & Philipson, L. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206913200 · Cited by 238
Dimitriadis, G. D., Maratou, E., Kountouri, A., Board, M., & Lambadiari, V. (2021) · Nutrients · doi:10.3390/nu13010159 · Cited by 241
Epigenetic phenomena linked to diabetic complications
Pirola, L., Balcerczyk, A., Okabe, J., & El-Osta, A. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.188 · Cited by 239
“and endothelial-cell damage mediated by hyperglycemia (type 1 diabetes mellitus)”
BackgroundWendt, T., Tanji, N., Guo, J., Hudson, B. I., Bierhaus, A., Ramasamy, R., Arnold, B., Nawroth, P. P., Yan, S. F., D’Agati, V., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000065100.17349.ca · Cited by 239
Mitochondrial Medicine: Pharmacological targeting of mitochondria in disease
Armstrong, J. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707288 · Cited by 234
“…biochemical pathways including: (1) the polyol and hexosamine pathways; (2) the protein kinase C pathway; and (3) the formation of advanced glycation end products that are considered to play a key role in diabetic microvascular pathology (Nishikawa et al., 2000; Du et al., 2003; Brownlee, 2005).”
BackgroundInfluentialPericytes, an overlooked player in vascular pathobiology
Ferland-McCollough, D., Slater, S., Richard, J., Reni, C., & Mangialardi, G. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.008 · Cited by 230
“It has been suggested that hyperglycemia-related complications are due to the increased production of superoxide through an increased output of themitochondrial electron transport chain (Nishikawa et al., 2000).”
BackgroundWang, T., Li, Y., Cornel, E. J., Li, C., & Du, J. (2021) · ACS Nano · doi:10.1021/acsnano.1c02102 · Cited by 236
Mitochondrial dysfunction leads to telomere attrition and genomic instability
Liu, L., Trimarchi, J. R., Smith, P. J. S., & Keefe, D. L. (2002) · Aging Cell · doi:10.1046/j.1474-9728.2002.00004.x · Cited by 237
“Zygotes were incubated with 2.5 µM Fura-2/AM (Molecular Probes) in KSOM for 30 min at 37 °C then washed and calcium imaging was conducted at excitation wavelength of 334/380 nm and measured at emission wavelength of 520 nm using the Attofluor imaging system.”
MethodInfluentialDiabetic macular edema: new concepts in patho-physiology and treatment
Zhang, X., Zeng, H., Bao, S., Wang, N., & Gillies, M. C. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-27 · Cited by 230
“Hyperglycemia induces mitochondrial superoxide over-expression, and leads to the activation of the hexosamine pathway [67].”
BackgroundCacicedo, J. M., Yagihashi, N., Keaney, J. F., Ruderman, N. B., & Ido, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.177 · Cited by 233
Xue, M., Qian, Q., Adaikalakoteswari, A., Rabbani, N., Babaei-Jadidi, R., & Thornalley, P. J. (2008) · Diabetes · doi:10.2337/db06-1003 · Cited by 235
“There is an associated activation of protein kinase C (PKC), hexosamine pathway Olinked protein glycosylation and increased glycation by methylglyoxal and other dicarbonyls forming advanced glycation endproducts (AGEs) (10-12) .”
BackgroundResultDiabetic nephropathy: Is there a role for oxidative stress?
Sagoo, M. K., & Gnudi, L. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.040 · Cited by 233
Modulation of the JNK Pathway in Liver Affects Insulin Resistance Status
Nakatani, Y., Kaneto, H., Kawamori, D., Hatazaki, M., Miyatsuka, T., Matsuoka, T.-A., Kajimoto, Y., Matsuhisa, M., Yamasaki, Y., & Hori, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406963200 · Cited by 232
‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting
Ceriello, A., & Ihnat, M. A. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02967.x · Cited by 233
Newsholme, P., Keane, K. N., Carlessi, R., & Cruzat, V. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00141.2019 · Cited by 217
Curcumin attenuates diabetic encephalopathy in rats: Behavioral and biochemical evidences
Kuhad, A., & Chopra, K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.08.001 · Cited by 236
Cellular and molecular mechanisms of endothelial dysfunction in diabetes
Roberts, A. C., & Porter, K. E. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113500680 · Cited by 225
Metabolism of activated T lymphocytes
Maciolek, J. A., Alex Pasternak, J., & Wilson, H. L. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.006 · Cited by 224
“Mitogen and anti-CD3 TCR stimulation in human T cells showed induced GPD2 activity which likely contributed to the shift toward use of Glycerol-3-Phosphate as a mitochondrial energy source [9 ,89].”
BackgroundMitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases
Aranda-Rivera, A. K., Cruz-Gregorio, A., Aparicio-Trejo, O. E., & Pedraza-Chaverri, J. (2021) · Biomolecules · doi:10.3390/biom11081144 · Cited by 226
“As a consequence, ETS becomes overloaded, promoting O2 overproduction [139].”
BackgroundOxidative stress and myocardial injury in the diabetic heart
Ansley, D. M., & Wang, B. (2013) · The Journal of Pathology · doi:10.1002/path.4113 · Cited by 231
Skeletal muscle mitochondria: A major player in exercise, health and disease
Russell, A. P., Foletta, V. C., Snow, R. J., & Wadley, G. D. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.11.016 · Cited by 226
Metadata
- Authors
- Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., Giardino, I., & Brownlee, M.
- Affiliations
- Albert Einstein College of Medicine (US)
- The University of Osaka (JP)
- University of Iowa (US)
- Pfizer (United States) (US)
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- Brownlee, Michael
- ORCID
- Venue
- Nature
- Published
- 2000-04
- Volume
- 404
- Issue
- 6779
- Pages
- 787-790
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1529592271
- Cited by
- 4,277
- References
- 23
- Citations by year
- 2026: 83 · 2025: 98 · 2024: 97 · 2023: 107 · 2022: 140 · 2021: 151 · 2020: 169 · 2019: 124 · 2018: 141 · 2017: 164 · 2016: 171 · 2015: 200 · 2014: 220 · 2013: 206 · 2012: 242
- FWCI
- 73.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- mitochondrial superoxide, reactive oxygen species, endothelial cells, protein kinase C, advanced glycation end products, sorbitol accumulation, NF-κB activation, UCP1, manganese superoxide dismutase, mitochondrial uncoupling, diabetic vascular complications
- MeSH terms
- Uncoupling Protein 1, Animals, Aspartic Acid, Blood Glucose, Carbonyl Cyanide m-Chlorophenyl Hydrazone, Carrier Proteins, Cattle, Electron Transport, Endothelium, Vascular, Enzyme Activation, Hyperglycemia, Ion Channels, Malates, Membrane Proteins, Mitochondria, Multienzyme Complexes, Oxidoreductases, Protein Kinase C, Rotenone, Sorbitol, Succinate Dehydrogenase, Superoxide Dismutase, Thenoyltrifluoroacetone, Uncoupling Agents, NF-kappa B, Glycation End Products, Advanced, Reactive Oxygen Species, Mitochondrial Proteins, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.